#genetic disorders
NORD Applauds FDA Initiative to Develop New Regulatory Framework for Rare Disease Drug Development
NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has issued a strong statement of support for...
NORD Announces Request for Applications to Implement Two New Patient Registries on the IAMRARE Platform with Support from Critical Path Institute
NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has officially announced a new request for applications...
NORD Announces Request for Applications to Implement Two New Patient Registries on IAMRARE® Platform
NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has officially announced a new request for applications...
NORD Announces Request for Applications to Implement Two New Patient Registries on IAMRARE® Platform with Support from Critical Path Institute
NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has officially announced a new request for applications aimed at...
NORD and Critical Path Institute Announce Funding Opportunity to Launch Two New Patient Registries on the IAMRARE Platform
NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has officially announced a new request for applications aimed at...
NORD Announces Funding Opportunity to Launch Two New Rare Disease Patient Registries on the IAMRARE Platform
NORWELL, Mass., Oct. 21, 2026 — The National Organization for Rare Disorders (NORD®) has officially announced a new request for...
NORD and Critical Path Institute Announce Funding Opportunity to Launch Two New Rare Disease Patient Registries on the IAMRARE Platform
NORWELL, Mass., Oct. 21, 2026 — The National Organization for Rare Disorders (NORD®) has officially announced a new request for...
BioMarin, Jazz Pharmaceuticals, and Otsuka CEOs Join NORD Leadership for High-Level Dialogue on Turning Scientific Breakthroughs into Patient Progress
WASHINGTON, D.C. and NORWELL, Mass. — As the landscape of medical science continues to evolve at a breathtaking pace, the...
NORD Applauds FDA Initiative to Establish New Regulatory Framework for Rare Disease Drug Development
NORWELL, Mass. — In what patient advocates are hailing as a monumental step forward for millions of families, the National...
NORD Applauds FDA’s Landmark Initiative to Establish Tailored Regulatory Framework for Rare Disease Drug Development
NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has issued a resounding endorsement of the U.S. Food and...
